Hemorrhage Clinical Trials

263 recruitingLast updated: May 21, 2026

There are 263 actively recruiting hemorrhage clinical trials across 48 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 4, Phase 1, Early Phase 1. Top locations include Beijing, Beijing Municipality, China, Houston, Texas, United States, Baltimore, Maryland, United States. Updated daily from ClinicalTrials.gov.


Hemorrhage Trials at a Glance

263 actively recruiting trials for hemorrhage are listed on ClinicalTrialsFinder across 6 cities in 48 countries. The largest study group is Not Applicable with 93 trials, with the heaviest enrollment activity in Beijing, Houston, and Baltimore. Lead sponsors running hemorrhage studies include Beijing Tiantan Hospital, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, and Second Affiliated Hospital, School of Medicine, Zhejiang University.

Browse hemorrhage trials by phase

About Hemorrhage Clinical Trials

Looking for clinical trials for Hemorrhage? There are currently 24 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hemorrhage trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hemorrhage clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 263 trials

Recruiting

Ex Vivo Reproduction of Minimally Invasive Surgery With Hematoma Lysis Using Modified Tissue Plasminogen Activator for Intracerebral Hemorrhage

Bleeding DisordersIntracerebral HemorrhageHemorrhagic Risk Conditions
University Hospital, Lille1,126 enrolled1 locationNCT07411079
Recruiting
Not Applicable

Impact of NMES and HPRO on Recovery After SAH- Pilot Study

InflammationSubarachnoid HemorrhageMuscle Atrophy+1 more
University of Maryland, Baltimore30 enrolled1 locationNCT03201094
Recruiting
Phase 3

Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).

Eye DiseasesMacular Degeneration, WetSub-Macular Hemorrhage
King's College Hospital NHS Trust210 enrolled36 locationsNCT04663750
Recruiting
Not Applicable

Clinical Impact of Using IMPROVE to Select Patients for Carotid Revascularisation

Stroke, IschemicStrokeStroke (CVA) or TIA+7 more
Maastricht University Medical Center613 enrolled10 locationsNCT07556887
Recruiting
Not Applicable

Safety, Feasibility, and Efficacy of Non-invasive Vagus Nerve Stimulation (nVNS) in the Treatment of Aneurysmal Subarachnoid Hemorrhage

Subarachnoid Hemorrhage, Aneurysmal
Massachusetts General Hospital25 enrolled1 locationNCT05103566
Recruiting

Recovery of Consciousness Following Intracerebral Hemorrhage

Intra Cerebral Hemorrhage
Columbia University150 enrolled2 locationsNCT03990558
Recruiting
Not Applicable

Safety and Effectiveness of the KOKO Device to Treat Primary Abnormal Postpartum Uterine Bleeding or Hemorrhage

Postpartum HemorrhageHemorrhage, PostpartumImmediate Postpartum Hemorrhage
KOKO Medical Inc.72 enrolled19 locationsNCT06452355
Recruiting
Not Applicable

Early Motor-Cognitive Integrative Training on Cognitive and Motor Performance in Patients With Aneurysmal Subarachnoid Hemorrhage

Subarachnoid Aneurysm Hemorrhage
National Taiwan University Hospital18 enrolled1 locationNCT07588997
Recruiting
Phase 2

Efficacy of Daily IV Administration of Dornase Alfa up to 14 Days Post Subarachnoid Hemorrhage on Functional Independence at 6 Months

SAH (Subarachnoid Hemorrhage)Delayed Cerebral IschemiaRuptured Aneurysm of Intracranial Artery
Fondation Ophtalmologique Adolphe de Rothschild304 enrolled6 locationsNCT06723717
Recruiting
Phase 1

Safety of Erythropoietin and Melatonin for Very Preterm Infants With Intraventricular Hemorrhage

Intraventricular Hemorrhage of Prematurity
Johns Hopkins University60 enrolled1 locationNCT05617833
Recruiting
Phase 3

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

Atrial FibrillationIntracerebral Hemorrhage
Yale University700 enrolled187 locationsNCT03907046
Recruiting

Dome-Only Aneurysm Coiling in Severe Aneurysmal Subarachnoid Hemorrhage

Aneurysmal Subarachnoid Hemorrhage
University of Louisville30 enrolled1 locationNCT07250958
Recruiting
Not Applicable

Deployment of Irrigating Intraventricular Catheter System for Intraventricular Hemorrhage

Intraventricular Hemorrhage (IVH)
Icahn School of Medicine at Mount Sinai17 enrolled1 locationNCT05970549
Recruiting
Not Applicable

Evaluating a Prototype CT Scan for ICH Evacuation

Intracerebral Hemorrhage
Icahn School of Medicine at Mount Sinai15 enrolled1 locationNCT07455201
Recruiting
Phase 4

Carbetocin Uterotonic Treatment in Twin Pregnancies for Prevention of Postpartum Hemorrhage

Postpartum HemorrhageTwin Pregnancy
Sheba Medical Center120 enrolled1 locationNCT07401524
Recruiting

CLOT-LESS - CLOsure Tailored: LEss Antithrombotic Strategy After LAAC for Stroke Prevention

Atrial FibrillationThromboembolismLeft Atrial Appendage Closure+4 more
National Medical Research Center for Therapy and Preventive Medicine464 enrolled1 locationNCT07575867
Recruiting
Not Applicable

Onyx™ Liquid Embolic IDE Clinical Study

TraumaUlcerGI Bleed+2 more
Medtronic Endovascular119 enrolled16 locationsNCT06742801
Recruiting

Improving the Prognosis for Cerebral Hemorrhage A Study of Clinical, Biological, and Imaging Markers

Intracerebral Hemorrhage (ICH)
University Hospital, Tours10,000 enrolled4 locationsNCT07444853
Recruiting
Not Applicable

Vitamin D for Acute Intracerebral Hemorrhage

Intracerebral Hemorrhage
The University of Hong Kong40 enrolled1 locationNCT07458815
Recruiting
Phase 4

Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)

Aneurysmal Subarachnoid Hemorrhage
Second Affiliated Hospital of Nanchang University424 enrolled25 locationsNCT06284642